|
|||||
|
|
Overall survival associated with CDK4/6 inhibitors in patients with HR+/HER2– metastatic breast cancer in the United States: A SEER-Medicare population-based study |
|
| Authors: | Ravi K Goyal PhD Hua Chen MD PhD Susan M Abughosh PhD Holly M Holmes MD MS AGSF Sean D Candrilli PhD Michael L Johnson PhD |
| Institution: | 1. Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Houston, Texas, USA;2. Division of Geriatric and Palliative Medicine, McGovern Medical School, University of Texas, Houston, Texas, USA;3. RTI Health Solutions, Research Triangle Park, North Carolina, USA |
| Abstract: | |
| Keywords: | CDK4/6 inhibitors metastatic breast cancer overall survival palbociclib SEER Medicare |